Treatment satisfaction of patients undergoing ranibizumab therapy for neovascular age-related macular degeneration in a real-life setting

CONTEXT: Treatment satisfaction with a loading phase of monthly injections for 3 months followed by a pro-re-nata regimen of ranibizumab in neovascular age-related macular degeneration (nAMD) remains unclear. AIMS: The aim was to evaluate the treatment satisfaction of persons with nAMD treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Gohil, Rishma, Crosby-Nwaobi, Roxanne, Forbes, Angus, Burton, Ben J, Hykin, Philip, Sivaprasad, Sobha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889099/
https://www.ncbi.nlm.nih.gov/pubmed/27307715
http://dx.doi.org/10.2147/PPA.S105536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889099/
https://www.ncbi.nlm.nih.gov/pubmed/27307715
http://dx.doi.org/10.2147/PPA.S105536

Ejemplares similares